Sleep and behavior in children and adolescents with tuberous sclerosis complex

Sleep disorders are frequent in tuberous sclerosis complex (TSC) during the developmental age but are not well characterized. Forty‐six TSC patients and 46 healthy age‐ and sex‐matched controls were enrolled. Their parents completed the Sleep Disturbances Scale for Children (SDSC) and the Child Behavior Checklist (CBCL). A total of 17.4% of the TSC patients obtained a total pathologic score at the SDSC versus 4.4% in the control group (p = 0.024). 45.7% of individuals with TSC reported a pathologic score in at least one of the factors. We found a statistically significant difference between the TSC cohort and healthy controls for most of the CBCL scales scores. A significant relationship was found between the Total SDSC score and the Total CBCL score (R‐square = 0.387, p < 0.0001), between the Total SDSC score and the Internalizing and Externalizing areas scores (R‐square = 0.291, p < 0.0001 and R‐square = 0.350, p < 0.0001, respectively) of the CBCL. Sleep disorders are more frequent in TSC than in the general population and correlate with behavior. The use of SDSC and CBCL is proposed as part of the surveillance of TSC patients in the developmental age.

[1]  A. Vignoli,et al.  Sleep disturbances in Italian children and adolescents with epilepsy: A questionnaire study , 2020, Epilepsy & Behavior.

[2]  N. Rensing,et al.  Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex , 2020, Neurobiology of Disease.

[3]  M. Jaatun,et al.  TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study , 2018, Orphanet Journal of Rare Diseases.

[4]  D. Pearson,et al.  A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND) , 2018, American journal of medical genetics. Part C, Seminars in medical genetics.

[5]  A. Vignoli,et al.  Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2. , 2018, European journal of medical genetics.

[6]  C. Oliver,et al.  A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex , 2018, Journal of Neurodevelopmental Disorders.

[7]  J. Lipton,et al.  Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy. , 2017, Cell reports.

[8]  P. J. Vries,et al.  Neurological and neuropsychiatric aspects of tuberous sclerosis complex , 2015, The Lancet Neurology.

[9]  T. Güttler,et al.  The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation , 2015, Cell.

[10]  P. D. de Vries,et al.  Advances in the treatment of tuberous sclerosis complex , 2015, Current opinion in psychiatry.

[11]  E. Roach,et al.  Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.

[12]  B. King,et al.  Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. , 2015, Pediatric neurology.

[13]  Sun-Mee Lee,et al.  Melatonin Inhibits mTOR-Dependent Autophagy during Liver Ischemia/Reperfusion , 2014, Cellular Physiology and Biochemistry.

[14]  D. Krueger Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex , 2013, Current Treatment Options in Neurology.

[15]  C. Galluccio,et al.  Application of the sleep disturbance scale for children (SDSC) in preschool age. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[16]  G. Stores Aspects of sleep disorders in children and adolescents , 2009, Dialogues in clinical neuroscience.

[17]  J. Osborne,et al.  Effect of Melatonin Dosage on Sleep Disorder in Tuberous Sclerosis Complex , 2005, Journal of child neurology.

[18]  O. Bruni,et al.  Sleep disorders in children with neurologic diseases. , 2001, Seminars in pediatric neurology.

[19]  J. Osborne,et al.  Use of melatonin to treat sleep disorders in tuberous sclerosis , 1999, Developmental medicine and child neurology.

[20]  O. Bruni,et al.  The Sleep Disturbance Scale for Children (SDSC) Construct ion and validation of an instrument to evaluate sleep disturbances in childhood and adolescence , 1996, Journal of sleep research.

[21]  O. Bruni,et al.  Sleep disorders in tuberous sclerosis: a polysomnographic study , 1995, Brain and Development.

[22]  G. Stores,et al.  SLEEP DISORDER AND EPILEPSY IN CHILDREN WITH TUBEROUS SCLEROSIS: A QUESTIONNAIRE‐BASED STUDY , 1994, Developmental medicine and child neurology.

[23]  A. Hunt Development, behaviour and seizures in 300 cases of tuberous sclerosis. , 2008, Journal of intellectual disability research : JIDR.

[24]  J. Osborne,et al.  Epidemiology of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.

[25]  A. Korczyn,et al.  [Sleep disturbances]. , 2017, Harefuah.